ArticleAnnals of translational medicine2020

Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study.

Chen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.